Delivery Order SPE2DB24D2011-SPE2DB24FBNYF

Award Date 3/12/24
Potential Completion Date 3/13/24
Potential Value $14K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $15,028.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Bupropion HCL XL 300 mg tablets in quantities of 500 per bottle. This is a firm-fixed-price delivery order contract with a completion date of February 13, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Bupropion HCL XL 300 mg tablets. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The contract has a ceiling value of $9,298.78 and a period of performance through February 2024. The contract was awarded on a...
This contract award, valued at $29,606.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,323,524 units of Bupropion HCL XL 300 mg tablets, with a completion date of January 16, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Bupropion HCL XL 300 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,145.68, and has an ultimate completion date of April 26, 2024. AmerisourceBergen Drug Corp, a subsidiary of the Cencora, Inc. parent company, holds a significant Indefinite Delivery Contract (IDC) with the DLA...
The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564034116 - Bupropion HCL XL 300 mg Tablets in 500 count packages. The contract has a ceiling value of $5,364.72 and a performance period through March 22, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger $999,999,999.00 indefinite delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $1,111.40, is for the delivery of Bupropion HCL XL 300 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 12, 2024. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a significant supplier of pharmaceutical products and...
This federal contract award, valued at $1,583.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for Bupropion HCL XL 300 mg Tablets, with an ultimate completion date of November 13, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, with no major subcontractors...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,000.80, is a firm fixed-price delivery order for the supply of Bupropion HCL XL 150 mg tablets. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. Both companies are for-profit organizations registered in the System...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $16,351.77, is a delivery order for the supply of Bupropion HCL XL 300 mg tablets. The award has a period of performance through February 1, 2024 and utilizes a firm-fixed price pricing structure. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
This federal contract award is for the delivery of Bupropion HCL XL 300 mg tablets in quantities of 500 to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, on February 29, 2024, with a ceiling value of $3,774.68 and an ultimate completion date of March 1, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the...
  • SPE2DB24D2011
    Indefinite Delivery Contract
  • SPE2DB24D2011-SPE2DB24FBNYF
    Delivery Order

This federal contract award, with identification number SPE2DB24D2011|SPE2DB24FBNYF, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Bupropion HCL XL 300 mg tablets, a pharmaceutical product, with a ceiling value of $13,838.52 and a completion date of March 13, 2024.

The contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally.

Generated 5/14/25, 10:31 AM